Search

Endocrine Surgery

A019

REPRODUCTIVE FACTORS, OBESITY, AND RISK OF THYROID CANCER AMONG WOMEN: A MULTICENTER RESEARCH NETWORK ANALYSIS

Endocrine Surgery

Madison N Hearn, BS; Neerav Goyal, MD, MPH; Tonya King, PhD; David Goldenberg, MD, FACS

Penn State College of Medicine


A020

ANAPLASTIC THYROID CANCER MANAGEMENT AND OUTCOMES: 20-YEAR SINGLE INSTITUTION EXPERIENCE

Endocrine Surgery

Shannon S Wu1; Eric Lamarre, MD2; Anirudh Yalamanchali, MD, MS2; Philip Brauer3; Chandana A Reddy2; Emrullah Yilmaz, MD2; Neil Woody, MD2; Jamie Ku, MD2; Brandon Prendes, MD2; Christian Nasr, MD2; Mario Skugor, MD2; Katherine Heiden, MD2; Deborah Chute, MD2; Jeffrey Knauf, PhD4; Shauna R Campbell, DO2; Shlomo Koyfman, MD2; Jessica Geiger, MD2; Joseph Scharpf, MD2

1Cleveland Clinic Lerner College of Medicine; 2Head and Neck Institute, Cleveland Clinic; 3Case Western Reserve University School of Medicine; 4Lerner Research Institute, Cleveland Clinic


A021

TRANSORAL ENDOSCOPIC THYROIDECTOMY VIA THE VESTIBULAR APPROACH (TOETVA) IN PATIENTS WITH GRAVES' DISEASE: A NORTH AMERICAN CASE SERIES

Endocrine Surgery

Katherine Tai1; Sallie Long, MD1; Victoria Yu, MD1; Rachel Weitzman1; Victoria Banuchi, MD1; Jonathon Russell, MD2

1Weill Cornell Medicine Otolaryngology Head and Neck Surgery; 2Johns Hopkins Otolaryngology-Head and Neck Surgery


A022

RISK STRATIFICATION OF LATERAL NECK RECURRENCE FOR PN1A PAPILLARY THYROID CANCER BASED ON THE NUMBER OF CENTRAL METASTATIC LYMPH NODES AND PRIMARY TUMOR SIZE

Endocrine Surgery

Siyuan Xu; Hui Huang; Shaoyan Liu; Jie Liu

Department of Head and Neck Surgical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College


A023

NEOADJUVANT SELECTIVE RET INHIBITOR FOR MEDULLARY THYROID CANCER: A CASE SERIES

Endocrine Surgery

Kevin J Contrera, MD, MPH; Maria K Gule-Monroe, MD; Maria E Cabanillas, MD; Mimi I Hu, MD; Naifa L Busaidy, MD; Ramona Dadu, MD; Steven G Waguespack, MD; Jennifer Wang, MD; Jeffery Myers, MD, PhD; Elizabeth G Grubbs, MD; Vivek Subbiah, MD; Michelle D Williams, MD; Mark E Zafereo, MD

UT MD Anderson Cancer Center


A024

SHARED DECISION-MAKING IN THE MANAGEMENT OF INDETERMINATE THYROID NODULES

Endocrine Surgery

David Forner, MD, MSc1; Victoria Taylor, BA1; Christopher W Noel, MD2; Brooke Turner, MD1; Paul Hong, MD, MSc1; Stephanie Johnson-Obaseki, MD, MPH3; David P Goldstein, MD, MSc2; Matthew H Rigby, MD, MPH1; S. Mark Taylor, MD1; Jonathan R Trites, MD1; Martin Corsten, MD1

1Dalhousie University; 2University of Toronto; 3University of Ottawa


A025

HEALTH CARE DISPARITIES AND RATES OF MALIGNANCY AMONGST CHILDREN WITH SINGLE THYROID NODULES

Endocrine Surgery

Z. Jason Qian, MD1; Eric Pineda, BS2; Hilary Seeley, MD1; Gary Hartman, MD1; Julia Noel, MD1; Lisa A Orloff, MD1; Kara D Meister, MD1

1Stanford University; 2Tulane University


A026

COMPARISON OF RISK FACTORS AND POSTOPERATIVE OUTCOMES IN PRIMARY AND SECONDARY/TERTIARY HYPERPARATHYROIDISM

Endocrine Surgery

Ryan M Kong, BS; Jennifer Liang, MD; Natalya Chernichenko, MD

SUNY Downstate Health Sciences University


A027

FACTORS ASSOCIATED WITH REFUSAL OF SURGERY IN DIFFERENTIATED THYROID CARCINOMA

Endocrine Surgery

Aman Prasad, BS1; Ryan M Carey, MD2; Robert M Brody, MD2; Steven B Cannady, MD2; Jason G Newman, MD2; Jason Brant, MD2; Karthik Rajasekaran, MD2

1Perelman School of Medicine at the University of Pennsylvania; 2Department of Otorhinolaryngology: Head and Neck Surgery, University of Pennsylvania, Perelman School of Medicine